HBV Mutation Detail Information

> M204I Search Result


Mutation Information
Mutation Site M204I
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.L180M+rt.M204I;rt.V173L+rt.M204I;rt.V207I+rt.M204I;rt.V173L+rt.L180M+rt.M204I;rt.V207I+rt.L180M+rt.M204I;rt.V207I+rt.V173L+rt.M204I;rt.V207I+rt.V173L+rt.L180M+rt.M204I
Relevant Drug lamivudine (LAM)
Literature Information
PubMed PMID 16378967
Disease HBV infection
Published Year 2006
Journal Journal of virology
Title Dynamics of hepatitis B virus resistance to lamivudine.
Author Pallier C,Castéra L,Soulier A,Hézode C,Nordmann P,Dhumeaux D,Pawlotsky JM
Evidence Virological breakthrough was preceded by 2 to 4 months by the emergence of quasispecies variants bearing amino acid substitutions at RT position 204, i., within the YMDD catalytic motif (rtM204V/I).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation